Related Topics News - Drugs

     
 < Previous page   Detail   |   Print    Next page > 
     
《大行》瑞銀降聯邦制藥目標價至17.6元 去年業績符預期
2026-03-26T  
聯邦制藥:UBT251注射液II期臨床研究達預期目標 將盡快啟動III期研究
2026-03-25T  
《業績》聯邦制藥全年純利20.86億人民幣跌21.6% 末期息派26分
2026-03-25T  
《業績》海螺環保全年虧損2.28億人民幣 盈轉虧
2026-03-24T  
《盈警》金活醫藥集團預計去年溢利減少70%-75%
2026-03-24T  
新華製藥子公司獲得布洛芬顆粒藥品註冊證書
2026-03-23T  
《業績》白雲山全年淨利潤29.83億人民幣增5.2% 末期息派45分
2026-03-22T  
《港股》恆指半日跌432點 騰訊下滑 小米逆市抽高
2026-03-19T  
《大行》里昂升康哲藥業目標價至16.5元 重申「跑贏大市」評級
2026-03-19T  
《大行》大和降金斯瑞生物科技目標價至21元 續予「買入」評級
2026-03-18T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.